Cargando…
Exonic variants in multiple myeloma patients associated with relapsed/ refractory and response to bortezomib regimens
Novel treatment in multiple myeloma represented by proteasome inhibitors, immunomodulatory drugs and monoclonal antibodies have produced a deep response. However, relapses are possible, and all classes of drugs are refractory to patients. Next-generation sequencing has improved our understanding of...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716956/ https://www.ncbi.nlm.nih.gov/pubmed/35002457 http://dx.doi.org/10.1016/j.sjbs.2021.09.017 |